YELLOW FEVER
Drug
SANOFI PASTEUR INC.
Total Payments
$42.2M
Transactions
751
Doctors
1
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $29.4M | 451 | 1 |
| 2018 | $12.8M | 298 | 0 |
| 2017 | $3,000 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $42.2M | 751 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| STA00011 Stamaril Yellow Fever | SANOFI PASTEUR INC. | $42.2M | 1 |
Top Doctors Receiving Payments for YELLOW FEVER
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Oakland, CA | $42.2M | 750 |
| , M.D | Family Medicine | Fountain Valley, CA | $1,500 | 1 |
Ad
Manufacturing Companies
- SANOFI PASTEUR INC. $42.2M
Product Information
- Type Drug
- Total Payments $42.2M
- Total Doctors 1
- Transactions 751
About YELLOW FEVER
YELLOW FEVER is a drug associated with $42.2M in payments to 1 healthcare providers, recorded across 751 transactions in the CMS Open Payments database. The primary manufacturer is SANOFI PASTEUR INC..
Payment data is available from 2017 to 2019. In 2019, $29.4M was paid across 451 transactions to 1 doctors.
The most common payment nature for YELLOW FEVER is "Unspecified" ($42.2M, 100.0% of total).
YELLOW FEVER is associated with 1 research study, including "STA00011 Stamaril Yellow Fever" ($42.2M).